NASDAQ:MMSI - Merit Medical Systems Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$53.55 -0.98 (-1.80 %)
(As of 12/18/2018 04:00 PM ET)
Previous Close$54.53
Today's Range$53.24 - $55.25
52-Week Range$41.55 - $66.34
Volume383,500 shs
Average Volume389,404 shs
Market Capitalization$3.09 billion
P/E Ratio41.84
Dividend YieldN/A
Beta1.22
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates advanced non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:MMSI
Previous Symbol
CUSIP58988910
Phone801-253-1600

Debt

Debt-to-Equity Ratio0.20
Current Ratio2.77
Quick Ratio1.47

Price-To-Earnings

Trailing P/E Ratio41.84
Forward P/E Ratio32.07
P/E Growth2.59

Sales & Book Value

Annual Sales$727.85 million
Price / Sales4.03
Cash Flow$2.2443 per share
Price / Cash Flow23.86
Book Value$13.47 per share
Price / Book3.98

Profitability

EPS (Most Recent Fiscal Year)$1.28
Net Income$27.52 million
Net Margins4.72%
Return on Equity10.86%
Return on Assets6.55%

Miscellaneous

Employees4,876
Outstanding Shares54,830,000
Market Cap$3.09 billion
OptionableOptionable

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its earnings results on Thursday, October, 25th. The medical instruments supplier reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.05. The medical instruments supplier had revenue of $221.66 million for the quarter, compared to the consensus estimate of $217.62 million. Merit Medical Systems had a return on equity of 10.86% and a net margin of 4.72%. View Merit Medical Systems' Earnings History.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Merit Medical Systems.

What price target have analysts set for MMSI?

9 Wall Street analysts have issued 12 month price objectives for Merit Medical Systems' shares. Their forecasts range from $58.00 to $79.00. On average, they expect Merit Medical Systems' stock price to reach $68.4444 in the next year. This suggests a possible upside of 27.8% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.

What is the consensus analysts' recommendation for Merit Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.

What are Wall Street analysts saying about Merit Medical Systems stock?

Here are some recent quotes from research analysts about Merit Medical Systems stock:
  • 1. Needham & Company LLC analysts commented, "MMSI announced it is has acquired substantially all of the assets of Vascular Insights (private) for $40M of cash upfront and up to $20M in milestone payments. Vascular Insights’ ClariVein products are used to treat superficial venous disease and serve an estimated ~$700M market. MMSI expects the deal to be ~$0.02 dilutive and between $0.00-0.02 accretive to 2018 and 2019 non-GAAP EPS, respectively, and to contribute between $10-11M in revenue in 2019. The Vascular Insights deal is consistent with both our investment thesis and MMSI’s M&A strategy and we reiterate our Buy rating." (12/17/2018)
  • 2. According to Zacks Investment Research, "Merit Medical exited the third quarter on a solid note, with earnings and revenues beating the consensus mark. Solid growth in the Cardiovascular segment is a positive along with expansion in gross margin. Solid international growth buoys optimism. Management is optimistic about the alliance with NinePoint Medical. The recent acquisition of product distribution agreements for the DirectACCESS Medical PTA Balloon Catheter is encouraging as well. The company also became the exclusive worldwide distributor for the Q50 PLUS Stent Graft Balloon. Recently, the company received FDA 510(k) clearance for a series of new tracheal/bronchial mini-stents.  The company also received 510(k) clearance for EmboCube product line. However, surging operating expenses is a concern. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes." (10/29/2018)

Has Merit Medical Systems been receiving favorable news coverage?

Media stories about MMSI stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Merit Medical Systems earned a media sentiment score of 1.9 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.

Who are some of Merit Medical Systems' key competitors?

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the folowing people:
  • Fred P. Lampropoulos, Chairman, President & Chief Executive Officer
  • Ronald A. Frost, Chief Operating Officer
  • Raul Parra, Chief Financial Officer
  • Joseph Pierce, Chief Information Officer
  • Jason Treft, Chief Technology Officer

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.59%), Vanguard Group Inc. (9.64%), Vanguard Group Inc (9.64%), Dimensional Fund Advisors LP (3.78%), Eagle Asset Management Inc. (3.74%) and Partner Fund Management L.P. (2.46%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Richard W Edelman and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.

Which institutional investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, JPMorgan Chase & Co., Royce & Associates LP, Man Group plc, Partner Fund Management L.P., Perceptive Advisors LLC, Eagle Boston Investment Management Inc. and Aristotle Capital Boston LLC. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Michael E Stillabower, Nolan E Karras and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.

Which institutional investors are buying Merit Medical Systems stock?

MMSI stock was acquired by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Vanguard Group Inc, Vanguard Group Inc., Peregrine Capital Management LLC, Kornitzer Capital Management Inc. KS, Thrivent Financial for Lutherans and Castleark Management LLC. View Insider Buying and Selling for Merit Medical Systems.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $53.55.

How big of a company is Merit Medical Systems?

Merit Medical Systems has a market capitalization of $3.09 billion and generates $727.85 million in revenue each year. The medical instruments supplier earns $27.52 million in net income (profit) each year or $1.28 on an earnings per share basis. Merit Medical Systems employs 4,876 workers across the globe.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is http://www.merit.com.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]


MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  241 (Vote Outperform)
Underperform Votes:  209 (Vote Underperform)
Total Votes:  450
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel